Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov;20(11):7913-7922.
doi: 10.1002/alz.14280. Epub 2024 Oct 12.

External validation of dementia prediction models in Black or African American and White older adults: A longitudinal population-based study in the United States

Affiliations

External validation of dementia prediction models in Black or African American and White older adults: A longitudinal population-based study in the United States

Klodian Dhana et al. Alzheimers Dement. 2024 Nov.

Abstract

Introduction: Identifying people at high risk of Alzheimer's disease (AD) dementia allows for timely intervention, which, if successful, will result in preventing or delaying the onset of the disease.

Methods: Utilizing data from the Chicago Health and Aging Project (CHAP; n = 2130), we externally evaluated four risk-prediction models for AD dementia, including Cardiovascular Risk Factors, Aging, and Dementia (CAIDE), Australian National University Alzheimer's Disease Risk Index (ANU-ADRI), Brief Dementia Screening Indicator (BDSI), and Dementia Risk Score (DRS), in Black or African American and White adults.

Results: BDSI had the highest discriminate abilities for AD dementia (c-statistics of 0.79 in Black and 0.77 in White adults), followed by ANU-ADRI, within the age range and follow-up period of the original development cohort. CAIDE had the lowest discriminating power (c-statistic ≤0.55). With increasing follow-up periods (i.e., 10-15 years), the discrimination abilities for all models declined.

Discussion: Because of racial disparities in AD dementia and longer preclinical and prodromal stages of disease development, race-specific models are needed to predict AD risk over 10 years.

Highlights: Utilizing risk-prediction models to identify individuals at higher risk of Alzheimer's disease (AD) dementia could benefit clinicians, patients, and policymakers. Clinicians could enroll high-risk individuals in clinical trials to test new risk-modifiable treatments or initiate lifestyle modifications, which, if successful, would slow cognitive decline and delay the onset of the disease. Current risk-prediction models had good discriminative power during the first 6 years of follow-up but decreased with longer follow-up time. Acknowledging the longer preclinical phase of AD dementia development and racial differences in dementia risk, there is a need to develop race-specific risk-prediction models that can predict 10 or 20 years of risk for AD and related dementias.

Keywords: Alzheimer's disease; Black or African American; White; dementia; risk assessment; validation.

PubMed Disclaimer

Conflict of interest statement

Klodian Dhana is funded by the Alzheimer's Association and National Institutes of Health (NIH) research grants and reports no conflicts of interest. Lisa L. Barnes, Todd Beck, Anisa Dhana, Xiaoran Liu, Pankaja Desai, Ted K.S. Ng, Denis A. Evans, and Kumar B. Rajan report no conflicts of interest. Author disclosures are available in the supporting information.

Figures

FIGURE 1
FIGURE 1
Calibration plot of CAIDE and DRS risk‐prediction models for Alzheimer's disease in the Chicago Health and Aging Project (CHAP). CAIDE predicts the risk of dementia during 20 years of follow‐up, whereas DRS predicts it during 5 years of follow‐up. In CHAP, we censored follow‐up data according to the prediction models and data availability. Recalibration consists of updating the intercept for the CAIDE model, whereas for the DRS model, it consists of updating the baseline survival function and the mean predictor values. The dashed diagonal line shows the ideal calibration between predicted and observed values. CAIDE, Cardiovascular Risk Factors, Aging, and Dementia; DRS, Dementia Risk Score.

Similar articles

Cited by

References

    1. Dhana K, Beck T, Desai P, Wilson RS, Evans DA, Rajan KB. Prevalence of Alzheimer's disease dementia in the 50 US states and 3142 counties: a population estimate using the 2020 bridged‐race postcensal from the national center for health statistics. Alzheimers Dementia. 2023;19(10):4388‐4395. doi: 10.1002/alz.13081 - DOI - PMC - PubMed
    1. Cummings JL, Goldman DP, Simmons‐Stern NR, Ponton E. The costs of developing treatments for Alzheimer's disease: a retrospective exploration. Alzheimers Dementia. 2022;18(3):469‐477. doi: 10.1002/alz.12450 - DOI - PMC - PubMed
    1. GBD 2016 Neurology Collaborators . Global, regional, and national burden of neurological disorders, 1990‐2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(5):459‐480. doi: 10.1016/S1474-4422(18)30499-X - DOI - PMC - PubMed
    1. Dhana K, Franco OH, Ritz EM, et al. Healthy lifestyle and life expectancy with and without Alzheimer's dementia: population based cohort study. BMJ. 2022:e068390. Published online April 13. doi: 10.1136/bmj-2021-068390 - DOI - PMC - PubMed
    1. Dhana K, Evans DA, Rajan KB, Bennett DA, Morris MC. Healthy lifestyle and the risk of Alzheimer dementia. Neurology. 2020;95(4):e374‐e383. doi: 10.1212/wnl.0000000000009816 - DOI - PMC - PubMed

Publication types